Alpha-Synuclein Transmission and Mitochondrial Toxicity in Primary Human Foetal Enteric Neurons In Vitro

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Neurotoxicity research

• Publication date

  2013-09-12

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s12640-013-9420-5PMID 24026637
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Enteric alpha‐synuclein expression is increased in Parkinson's disease but not Alzheimer's disease

  2013cited by this paper
• Is alpha‐synuclein in the colon a biomarker for premotor Parkinson's Disease? Evidence from 3 cases

  2012cited by this paper
• High-resolution respirometry: OXPHOS protocols for human cells and permeabilized fibers from small biopsies of human muscle.

  2012cited by this paper
• NAD+ metabolism and oxidative stress: the golden nucleotide on a crown of thorns

  2012cited by this paper
• Alpha‐synuclein in colonic submucosa in early untreated Parkinson's disease

  2012cited by this paper
• Parkinson’s disease is not associated with gastrointestinal myenteric ganglion neuron loss

  2012cited by this paper
• Expression pattern and localization of alpha-synuclein in the human enteric nervous system.

  2012cited by this paper
• Age Related Changes in NAD+ Metabolism Oxidative Stress and Sirt1 Activity in Wistar Rats

  2011cited by this paper
• Parallel manifestations of neuropathologies in the enteric and central nervous systems

  2011cited by this paper
• Adaptation of microplate‐based respirometry for hippocampal slices and analysis of respiratory capacity

  2011cited by this paper
• α-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells.

  2011cited by this paper
• Direct Membrane Association Drives Mitochondrial Fission by the Parkinson Disease-associated Protein α-Synuclein*♦

  2011cited by this paper
• Mitochondrial Dysfunction: The Road to Alpha-Synuclein Oligomerization in PD

  2011cited by this paper
• Transmission of prions within the gut and towards the central nervous system

  2011cited by this paper
• Multi-organ distribution of phosphorylated α-synuclein histopathology in subjects with Lewy body disorders

  2010cited by this paper
• Colonic Biopsies to Assess the Neuropathology of Parkinson's Disease and Its Relationship with Symptoms

  2010cited by this paper
• MPTP-induced parkinsonism extends to a subclass of TH-positive neurons in the gut.

  2010cited by this paper
• α-Synuclein Promotes SNARE-Complex Assembly in Vivo and in Vitro

  2010cited by this paper
• α-Synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity

  2009cited by this paper
• Insoluble α-synuclein in alzheimer’s disease without lewy body formation

  2009cited by this paper
• Alpha-synuclein immunopositive aggregates in the myenteric plexus of the aging Fischer 344 rat.

  2009cited by this paper
• Faculty Opinions recommendation of Alpha-synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity.

  2009cited by this paper
• Propagation of Tau Misfolding from the Outside to the Inside of a Cell*

  2009cited by this paper
• Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein

  2009cited by this paper
• Cytoplasmic penetration and persistent infection of mammalian cells by polyglutamine aggregates

  2009cited by this paper
• Parkinson's disease: from monogenic forms to genetic susceptibility factors.

  2009cited by this paper
• Alpha-synuclein-immunopositive myenteric neurons and vagal preganglionic terminals: autonomic pathway implicated in Parkinson's disease?

  2008cited by this paper
• The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson's disease.

  2008cited by this paper
• Parkinson’s disease and the gut: a well known clinical association in need of an effective cure and explanation

  2008cited by this paper
• Promotion of cellular NAD+ anabolism: Therapeutic potential for oxidative stress in ageing and alzheimer’s disease

  2008cited by this paper
• Formation of Toxic Oligomeric α-Synuclein Species in Living Cells

  2008cited by this paper
• Human-based studies on alpha-synuclein deposition and relationship to Parkinson's disease symptoms.

  2008cited by this paper
• The role of MPTP in Parkinson's disease: connecting brain and gut?

  2008cited by this paper
• Clearance and deposition of extracellular alpha-synuclein aggregates in microglia.

  2008cited by this paper
• Human-based studies on α-synuclein deposition and relationship to Parkinson's disease symptoms

  2008cited by this paper
• Pathological lesions in colonic biopsies during Parkinson’s disease

  2008cited by this paper
• Mitochondria and neurodegeneration.

  2007cited by this paper
• Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.

  2007cited by this paper
• Common Inflammatory Mechanisms in Lewy Body Disease and Alzheimer Disease

  2007cited by this paper
• Resveratrol protects SH-SY5Y neuroblastoma cells from apoptosis induced by dopamine

  2007cited by this paper
• In Vitro Characterization of Pittsburgh Compound-B Binding to Lewy Bodies

  2007cited by this paper
• Parkinson's Disease Brain Mitochondrial Complex I Has Oxidatively Damaged Subunits and Is Functionally Impaired and Misassembled

  2006cited by this paper
• Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases

  2006cited by this paper
• Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology.

  2006cited by this paper
• Exogenous Induction of Cerebral ß-Amyloidogenesis Is Governed by Agent and Host

  2006cited by this paper
• Oxidative stress in the brain: novel cellular targets that govern survival during neurodegenerative disease.

  2005cited by this paper
• Expression of indoleamine 2,3‐dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons

  2005cited by this paper
• Insoluble alpha-synuclein in Alzheimer's disease without Lewy body formation.

  2005cited by this paper
• Metal ions and oxidative protein modification in neurological disease.

  2005cited by this paper
• Alpha-Synuclein Expression in the Developing Human Brain

  2004cited by this paper
• Assessment of proteasome activity in cell lysates and tissue homogenates using peptide substrates.

  2003cited by this paper
• Fine Structure and Biochemical Mechanisms Underlying Nigrostriatal Inclusions and Cell Death after Proteasome Inhibition

  2003cited by this paper
• Mitochondria, Oxidative Damage, and Inflammation in Parkinson's Disease

  2003cited by this paper
• Amyloid Precursor Protein, Presenilins, and α-Synuclein: Molecular Pathogenesis and Pharmacological Applications in Alzheimer's Disease

  2002cited by this paper
• The neuropathogenic contributions of lysosomal dysfunction

  2002cited by this paper
• Microtubule-associated Protein 1B Is a Component of Cortical Lewy Bodies and Binds α-Synuclein Filaments*

  2000cited by this paper
• Synaptic transmission induces transient Ca2+ concentration changes in cultured myenteric neurones

  2000cited by this paper
• Transmissible spongiform encephalopathies, amyloidoses and yeast prions: Common threads?

  2000cited by this paper
• Murine Glial Cells Regenerate NAD, After Peroxide‐Induced Depletion, Using Either Nicotinic Acid, Nicotinamide, or Quinolinic Acid as Substrates

  1998cited by this paper
• Alpha-synuclein in Lewy bodies.

  1997cited by this paper
• Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease

  1997cited by this paper
• Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.

  1997cited by this paper
• Mitochondria, Calcium Regulation, and Acute Glutamate Excitotoxicity in Cultured Cerebellar Granule Cells

  1996cited by this paper
• Aging, energy, and oxidative stress in neurodegenerative diseases

  1995cited by this paper
• Mitochondrial complex I deficiency in Parkinson's disease.

  1989cited by this paper
• Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease.

  1989cited by this paper
• Mitochondrial Complex I Deficiency in Parkinson's Disease

  1989cited by this paper
• Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay.

  1987cited by this paper
• Medicine and the Law

  1983cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper
• An improved cycling assay for nicotinamide adenine dinucleotide.

  1973cited by this paper

• Gastrointestinal, Respiratory, and Olfactory Neurotropism of Sars-Cov2 as a Possible Trigger of Parkinson’s Disease: Is a Multi-Hit Multi-Step Process on the Cards

  2023cites this paper
• Pathological Pathways and Alpha-Synuclein in Parkinson's Disease: A View from the Periphery.

  2023cites this paper
• Aggregation of alpha-synuclein in enteric neurons does not impact function in vitro

  2022cites this paper
• Analysis of alpha-synuclein amyloid fibrils and their effects on the cellular proteome

  2021cites this paper
• Cellular pathophysiology and basal ganglia dysfunction in Parkinson's disease: an overview

  2020cites this paper
• The role of environmental toxins and inflammation in Parkinson's disease pathophysiology: a historical perspective and research-based evidence

  2020cites this paper
• The Role of Oxidative Stress in Parkinson’s Disease

  2020cites this paper
• SocialWork 11-17-2017 Mitochondria : A Common Target for Genetic Mutations and Environmental Toxicants in Parkinson ’ s Disease

  2019cites this paper
• Extracellular Interactions of Alpha-Synuclein in Multiple System Atrophy

  2018cites this paper
• Autophagy in neuroinflammatory diseases.

  2017cites this paper
• Colonic Oxidative and Mitochondrial Function in Parkinson's Disease and Idiopathic REM Sleep Behavior Disorder

  2017cites this paper
• Mitochondria: A Common Target for Genetic Mutations and Environmental Toxicants in Parkinson’s Disease

  2017cites this paper
• Gastrointestinal Symptoms and Olfactory Disorder as Prodromal Non-motor Symptoms of Idiopathic Parkinson’s Disease compa-Hypothesis of Ascension in Idiopathic Parkinson ’ s Disease

  2017cites this paper
• Aszensionshypothese beim idiopathischen Parkinson-Syndrom

  2017cites this paper
• Gastrointestinal Symptoms and Olfactory Disorder as Prodromal Non-motor Symp- toms of Idiopathic Parkinson’s Disease

  2017cites this paper
• Hypothesis of Ascension in Idiopathic Parkinson’s Disease

  2017cites this paper
• The Complex Genetics behind Neurodegeneration and Susceptibility to Parkinson’s disease

  2017cites this paper
• Gastrointestinal Symptoms and Olfactory Disorder as Prodromal Non-motor Symptoms of Idiopathic Parkinson’s Disease compa-Hypothesis of Ascension in Idiopathic Parkinson ’ s Disease

  2017cites this paper
• Interference of α-Synuclein Uptake by Monomeric β-Amyloid1–40 and Potential Core Acting Site of the Interference

  2016cites this paper
• Intracellular Dynamics of Synucleins: "Here, There and Everywhere".

  2015cites this paper
• Upregulation of Glycolytic Enzymes, Mitochondrial Dysfunction and Increased Cytotoxicity in Glial Cells Treated with Alzheimer’s Disease Plasma

  2015cites this paper
• Pathogenesis of Parkinson disease—the gut–brain axis and environmental factors

  2015cites this paper
• The complex relationships between microglia, alpha-synuclein, and LRRK2 in Parkinson's disease.

  2015cites this paper
• Anticorps anti-alpha-synucléine et leurs méthodes d'utilisation

  2014cites this paper
• Considerations on the role of environmental toxins in idiopathic Parkinson’s disease pathophysiology

  2014cites this paper
• The emergence of the mitochondrial genome as a partial regulator of nuclear function is providing new insights into the genetic mechanisms underlying age-related complex disease

  2014cites this paper
• Ursache der Parkinson-Krankheit: Braak revisited

  2014cites this paper
• Products of the Parkinson's disease-related glyoxalase DJ-1, D-lactate and glycolate, support mitochondrial membrane potential and neuronal survival

  2014cites this paper
• Products of the Parkinson’s-disease related glyoxalase DJ-1, D-lactate and glycolate, support mitochondrial membrane potential and neuronal survival

  2014cites this paper
• The Role of Oxidative Stress in Parkinson's Disease

  2013cites this paper
• Neuroprotective Effects of Rosmarinic Acid on Ciguatoxin in Primary Human Neurons

  2013cites this paper
• Chemistry of Compounds Journal Evidence for the Use of Rosmarinic Acid as a Neuroprotective Agent: A Review

  year unknowncites this paper
• Gastrointestinal Symptoms and Olfactory Disorder as Prodromal Non-motor Symptoms of Idiopathic Parkinson’s Disease

  year unknowncites this paper